Global botox medical market is expected to grow at a CAGR of 7.9% to 2027

Published Date: April 7, 2021 |

Global botox medical market is expected to grow at a CAGR of 7.9% to 2027

Botulinum toxin A and B are prescription medicines which needs to be administered under medical supervision on account of the severe drug related adverse events such as headache, dysphagia, nausea, spread of toxic effects etc.

Browse the full report Botox Medical Market – Growth, Future Prospects, Competitive Analysis, 2020 – 2027 report at https://www.researchcorridor.com/botox-medical-market/

Botulinum toxin A is reigning the product segment for botox medical market. Constant rise in the elderly population worldwide and increasing disposable income among generation y population together provide a positive thrust for the botox medical market growth. It is a protein neurotoxin which has a molecular size of 150 KDa and exhibits its pharmacological activity by blocking the neuromuscular transmission by binding to the acceptor sites of motor or the sympathetic nerve terminals. It has a diverse clinical application for the treatment of overactive bladder, chronic migraine, axillary hyperhidrosis etc. Botulinum toxin B is going to record excellent market growth during the forecast period owing to the positive clinical studies investigation indicating its therapeutic efficacy in the treatment of cervical dystonia in adult population worldwide.

Dermatology clinics are currently dominating the end users segment for botox medical market. Significant increase in the baby boomer population worldwide having tremendous inclination for botulinum treatment to enhance the skin tonicity and increasing facial aesthetics by diminishing the ageing process and wrinkles on the facial skin surface. Hospitals are expected to record steady market growth in the near future on account of the significant rise in the number of patients visiting hospitals for administering botulinum toxin injection for treatment of medical conditions such as overactive bladder and cervical dystonia in adult population throughout the globe.

North America is presently leading the geography segment for botox medical market. Availability of large disposable income and influence of social medica and facial aesthetics products have a positive impetus on the botox medical market growth in the region. Existence of developed healthcare infrastructure and presence of major players such as Allergan, Plc. (Abbvie, Inc.), Galderma S.A., US Worldmed LLC., Evolus, Inc. further propel the market growth in the region. Europe is the 2nd largest regional segment for botox medical market. Rising prevalence of cervical dystonia and hyperactive urinary bladder primarily drives the market growth in the region. Asia Pacific is anticipated to be the fastest growing regional segment in the botox medical market. Increasing public awareness regarding clinical application of botox in the treatment of chronic migraine and axillary hyperhidrosis steers the market growth in the Asia Pacific region.

To know more about the study, request a report sample

Pharmaceutical manufacturers actively engaged in the production of botox medical are Allergan, Plc. (Abbvie, Inc.), Eisai Co. Ltd., US Worldmed LLC., Galderma S.A., Evolus, Inc., Hugel, Inc., Ipsen Limited (Mayroy SA)., Medytox, Inc., Merz Pharma., and Revance Therapeutics, Inc.

Key Market Movements:

  • Increasing demand for facial aesthetics among geriatric population worldwide
  • Significant increase in cervical dystonia and overactive bladder further accentuates the market growth
  • Supportive regulatory environment for the early adoption of botulinum toxins for medical purpose further propels the market growth
Fill the given form to request sample for Global botox medical market is expected to grow at a CAGR of 7.9% to 2027 Market Report [contact-form-7 id="143911" title="Request Sample"]
Fill the given form to inquiry before buying for Global botox medical market is expected to grow at a CAGR of 7.9% to 2027 Market Report [contact-form-7 id="143909" title="Inquiry Buying"]